First substantial mechanism for long term immunity from SARS-CoV-2 : T-cells

M. Leslie, “T cells found in COVID-19 patients ‘bode well’ for long-term immunity“, Science, doi:10.1126/science.abc8120.

A. Grifoni, et al, “Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals“, Cell, 14th May 2020.

J. Braun, L. Loyal, et al, “Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors“, medRχiv (not peer-reviewed, with comments), 22 April 2020.

34% of non-CV19 patients in Germany already had the Coronavirus spike protein specific helper T-cells. Due most likely to infection with prior common cold coronaviruses. That number is close to the percentage of “asymptomatic cases” we are seeing.

About ecoquant

See https://667-per-cm.net/about. Retired data scientist and statistician. Now working projects in quantitative ecology and, specifically, phenology of Bryophyta and technical methods for their study.
This entry was posted in American Association for the Advancement of Science, coronavirus, COVID-19, epidemiology, SARS-CoV-2 and tagged . Bookmark the permalink.

Leave a reply. Commenting standards are described in the About section linked from banner.

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.